Skip to main content
logo
ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
91.80
+0.12 (0.13%)
Oct 8, 2025, 6:01 AM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Generics and Other
320.03M
Log In
Log In
Log In
Log In
Upgrade
Rare Disease and Brands
294.34M
Log In
Log In
Log In
Log In
Upgrade
Generics, Established Brands, and Other
-
Log In
Log In
Log In
Log In
Upgrade
Generics, Established Brands, and Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Rare Disease
-
Log In
Log In
Log In
Log In
Upgrade
Rare Disease Growth
-
Log In
Log In
Log In
Log In
Upgrade
Generic Pharmaceutical Products
-
Log In
Log In
Log In
Log In
Upgrade
Generic Pharmaceutical Products Growth
-
Log In
Log In
Log In
Log In
Upgrade
Branded Pharmaceutical Products
-
Log In
Log In
Log In
Log In
Upgrade
Branded Pharmaceutical Products Growth
-
Log In
Log In
Log In
Log In
Upgrade
Royalties from Licensing Agreements
-
Log In
Log In
Log In
Log In
Upgrade
Royalties from Licensing Agreements Growth
-
Log In
Log In
Log In
Log In
Upgrade
Contract Manufactured Products
-
Log In
Log In
Log In
Log In
Upgrade
Contract Manufactured Products Growth
-
Log In
Log In
Log In
Log In
Upgrade
Product Development Services
-
Log In
Log In
Log In
Log In
Upgrade
Product Development Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
United States
604.99M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
24.42%
Log In
Log In
Log In
Log In
Upgrade
International
9.39M
Log In
Log In
Log In
Log In
Upgrade
Canada
-
Log In
Log In
Log In
Log In
Upgrade
Canada Growth
-
Log In
Log In
Log In
Log In
Upgrade